Botulinum Toxin Injections for Children With Excessive Drooling

Abstract

The objective of this study was to evaluate the feasibility of ultrasonography-guided injections of botulinum toxin A into the parotid glands of children with severe drooling (sialorrhea). Excessive drooling is common in children with chronic neurologic disorders. Preliminary observations in adults suggest that injections of botulinum toxin A into the parotid glands can decrease drooling, but the optimal dose, sites of injection, and concomitant use of imaging during injections and its use for children have not been established. Ultrasonography was used to guide the injection of botulinum toxin (10—25 IU) into both parotid glands of nine children with excessive drooling. Subjective and objective measures of the severity of drooling were collected before and after botulinum toxin A injections. A booster injection was provided if the initial response was inadequate. Injections were well tolerated, and no adverse reactions were observed. Ultrasonography revealed that the parotid gland showed a variable depth, extent, and vascularization. Eight of nine patients needed a booster injection after 1 month. Objective measures of drooling severity were improved in seven of nine patients. However, subjective improvement was reported in only three of nine patients, and this improvement was functionally significant in only one patient. Although intraparotid injection of botulinum toxin A is safe and causes a reduction in saliva production in children, the doses used in this study did not result in functionally significant improvement. Higher doses of botulinum toxin A in the parotid glands or concomitant injections into the submandibular glands can increase the efficacy of these injections. Variability in size, depth, and vascular supply of the parotid gland suggests the importance of ultrasonography guidance for optimizing injections. These results underscore the need for further studies to establish the efficacy of this treatment in children. (J Child Neurol 2005;20:120—123).

Get full access to this article

View all access options for this article.

References

Harris SR , Purdy AH : Drooling and its management in cerebral palsy. Dev Med Child Neurol 1987;29:807—811.

Nunn JH : Drooling: Review of the literature and proposals for management. J Oral Rehabil 2000;27:735—743.

Blasco PA , Allaire JH , Hollahan J. , et al, and the Participants of the Consortium on Drooling : Consensus Statement of the Consortium on Drooling. Washington, DC, UCPA, Inc., 1991 .

Naumann M. : Evidence-based medicine: Botulinum toxin in focal hyperhidrosis. J Neurol 2001;248(Suppl 1):31—33.

Heckmann M. , Ceballos-Baumann AO , Plewig G. : Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488—493.

Bhatia KP , Munchau A. , Brown P. : Botulinum toxin is a useful treatment in excessive drooling in saliva. J Neurol Neurosurg Psychiatry 1999;67:697.

Giess R. , Naumann M. , Werner E. , et al: Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2000;69:121—123.

Friedman Apa : Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkinsonism Relat Disord 2001;7:329—332.

Jost WH : Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 1999;14:1057.

10.

Porta M. , Gamba M. , Bertacchi G. , Vaj P. : Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538—540.

11.

O'Sullivan JD , Bhatia KP , Lees AJ : Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;55:606—607.

12.

Guntinas-Lichius O. , Eckel HE : Temporary reduction of salivation in laryngectomy patients with pharyngocutaneous fistulas by botulinum toxin A injection. Laryngoscope 2002;112:187—189.

13.

Ellies M. , Laskawi R. , Rohrbach-Volland S. , et al: Botulinum toxin to reduce saliva flow: Selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 2002;112:82—86.

14.

Jongerius PH , Joosten F. , Hoogen FJ , et al: The treatment of drooling by ultrasound-guided intraglandular injections of botulinum toxin type A into the salivary glands . Laryngoscope 2003;113:107—111.

15.

Ellies M. , Laskawi R. , Tormahlen G. , Gotz W. : The effect of local injection of botulinum toxin A on the parotid gland of the rat: An immunohistochemical and morphometric study. J Oral Maxillofac Surg 2000;58:1251—1256.

16.

Bothwell J. , Clarke K. , Dooley J. , et al: Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol 2002;27:18—22.

17.

Suskind DL , Tilton A. : Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73—81.

18.

Thomas-Stonell N. , Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988 ;3:73-78.

19.

Osborne JG , Gatling JH , Wells J. , et al: Observation and measurement of drooling by people with mental retardation. Ment Retard 1994;32:288—298.

20.

Reddihough D. , Johnson H. , Ferguson E. : The role of a saliva control clinic in the management of drooling. J Paediatr Child Health 1992;28:395—397.

21.

Jongerius PH , Rotteveel JJ , van den Hoogen F. , et al: Botulinum toxin A: A new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 2001;160:509—512.

22.

Pal PK , Calne DB , Calne S. , Tsui JK : Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244—247.

23.

Glickman S. , Deaney CN : Treatment of relative sialorrhoea with botulinum toxin type A: Description and rationale for an injection procedure with a case report. Eur J Neurol 2001;8:567—571.

24.

Mancini F. , Zangaglia R. , Cristina S. , et al: Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism . Mov Disord 2003;18:685—688.

25.

Lipp A. , Trottenberg T. , Schink T. , et al: A randomized trial of botulinum toxin A for treatment of drooling . Neurology 2003;61:1279—1281.

26.

Ellies M. , Rohrbach-Volland S. , Arglebe C. , et al: Successful management of drooling with botulinum toxin A in neurologically disabled children. Neuropediatrics 2002;33:327—330.